SCHEMBL10747393

SCHEMBL10747393

Fc1ccc2nc(-n3[se]c4ccccc4c3=S)nnc2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ METAP2 P50579 3/20 0.39
▸ TP53 P04637 3/20 0.36
▸ CYP3A4 P08684 2/20 0.36
▸ MAPT P10636 2/20 0.36
▸ CYP2C9 P11712 2/20 0.36
▸ CYP2C19 P33261 2/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ CASP1 P29466 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ MAPK10 P53779 1/20 0.36
▸ CASP7 P55210 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ KDM4E B2RXH2 2/20 0.32
▸ KMT2A Q03164 3/20 0.32
▸ MEN1 O00255 2/20 0.32
▸ HCRTR1 O43613 1/20 0.32
▸ RXFP1 Q9HBX9 1/20 0.31
▸ QSOX1 O00391 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10748283 0.85 METAP2 (0.36) METAP2TP53CYP3A4MAPTCYP2C9
SCHEMBL10746865 0.85 METAP2 (0.55) METAP2TP53CYP3A4MAPTCYP2C9
SCHEMBL10746433 0.80 KMT2A (0.38) MAPTNPC1CYP1A2RAB9ASMN1; SMN2
SCHEMBL10746662 0.72 METAP2 (0.38) METAP2TP53CYP3A4MAPTCYP2C9
SCHEMBL10501844 0.71 METAP2 (0.66) METAP2TP53CYP3A4MAPTCYP2C9
SCHEMBL10501084 0.71 METAP2 (0.68) METAP2TP53CYP3A4MAPTCYP2C9
SCHEMBL10501742 0.70 METAP2 (0.47) METAP2GLAMPIPHOSPHO1
SCHEMBL10746207 0.70 MEN1 (0.47) METAP2TP53CYP3A4MAPTCYP2C9
SCHEMBL10501361 0.70 MPI (0.51) METAP2MAPTSMN1; SMN2KDM4EALDH1A1
SCHEMBL10954133 0.69 METAP2 (0.46) METAP2TP53CYP3A4MAPTCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4711961-A Benzisoselenazolethiones and process for the treatment of various diseases in humans A. NATTERMANN & CIE GMBH (DE) 1987-12-08 — — US disclosed
EP-0154851-A1 Benzisoselenazolethiones,process for their preparation and pharmaceutical products containing these compounds A. Nattermann & Cie. GmbH (DE) 1985-09-18 — — EP disclosed
Send feedback